Issue navigation
Volume 36, Issue Supplement_2, September 2023
ISDE 2023 Congress Supplement - Abstracts submitted to the 19th ISDE World Congress for Esophageal Diseases
Abstracts
12. NEUROKININ A AND SUBSTANCE P SERUM CONCENTRATIONS CORRELATE WITH MOTILITY METRICS PREDISPOSING TO REFLUX, BUT NOT WITH ESOPHAGITIS PRESENCE IN GERD
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.001, https://doi.org/10.1093/dote/doad052.001
14. IMPACTS OF ADDITIONAL CYCLES OF NEOADJUVANT IMMUNOCHEMOTHERAPY ON ESOPHAGECTOMY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.002, https://doi.org/10.1093/dote/doad052.002
15. EFFECT OF ARTIFICIAL CAPNOTHORAX VS NON-CAPNOTHORAX DURING THORACOSCOPIC ESOPHAGECTOMY ON CIRCULATING TUMOR CELLS AND SURVIVAL IN ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.003, https://doi.org/10.1093/dote/doad052.003
16. THORACIC FRACTURES AND OTHER CHEST WALL ABNORMALITIES AFTER THORACOTOMY FOR ESOPHAGEAL CANCER: A RETROSPECTIVE COHORT STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.004, https://doi.org/10.1093/dote/doad052.004
17. OUTCOMES OF ESOPHAGEAL CANCER FROM SINGAPORE’S NATIONAL REGISTRY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.005, https://doi.org/10.1093/dote/doad052.005
18. ASSOCIATION OF TUMOR PATHOLOGICAL COMPLETE RESPONSE WITH THE USE OF METFORMIN DURING NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL CANCER PATIENTS: RETROSPECTIVE STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.006, https://doi.org/10.1093/dote/doad052.006
20. ADDITIONAL NEOADJUVANT IMMUNOTHERAPY DOESN’T INCREASE THE RISK OF ANASTOMOTIC LEAKAGE AFTER ESOPHAGECTOMY: A MULTICENTER RETROSPECTIVE COHORT STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.007, https://doi.org/10.1093/dote/doad052.007
24. A NOVEL TUMOR STAGING SYSTEM INCORPORATING CN STATUS FOR STRATIFYING EARLY STAGE ESOPHAGEAL SQUAMOUS CELL CARCINOMA PATIENTS AFTER TRIMODAL THERAPY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.008, https://doi.org/10.1093/dote/doad052.008
25. THE ROLE OF ADJUVANT THERAPY FOR PATIENTS WITH ESOPHAGEAL ADENOCARCINOMA UNDERGOING NEOADJUVANT THERAPY AND ESOPHAGECTOMY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.009, https://doi.org/10.1093/dote/doad052.009
27. OPLAH PROTEIN EXPRESSION STRATIFIES THE PROGNOSIS OF PATIENTS WITH SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.010, https://doi.org/10.1093/dote/doad052.010
31. MULTICENTER RANDOMIZED CLINICAL TRIAL OF CRT VS DCF AS INITIAL TREATMENT FOR SUBSEQUENT CONVERSION SURGERY FOR CLINICAL T4B ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.011, https://doi.org/10.1093/dote/doad052.011
32. QUALITY PERFORMANCE INDICATOR COMPLIANCE FOR THE TREATMENT OF OESOPHAGEAL ADENOCARCINOMA IN NEW ZEALAND
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.012, https://doi.org/10.1093/dote/doad052.012
33. QUALITY PERFORMANCE INDICATORS FOR THE SURGICAL TREATMENT OF OESOPHAGEAL CANCER- A SYSTEMATIC REVIEW
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.013, https://doi.org/10.1093/dote/doad052.013
34. EXTENDED RIGHT THORACIC APPROACH COMPARED WITH LIMITED LEFT THORACIC APPROACH FOR ESOPHAGEAL CANCER: TEN-YEAR SURVIVAL OF A PROSPECTIVE RANDOMIZED TRIAL
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.014, https://doi.org/10.1093/dote/doad052.014
39. HIGH PREOPERATIVE PLATELET TO LYMPHOCYTE RATIO IS ASSOCIATED WITH A GREATER RISK OF POSTOPERATIVE COMPLICATIONS AND RECURRENCES IN ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.015, https://doi.org/10.1093/dote/doad052.015
41. HIGH COMPREHENSIVE COMPLICATION INDEX AFTER MINIMALLY INVASIVE ESOPHAGECTOMY ASSOCIATED WITH POOR SHORT-TERM AND LONG-TERM OUTCOME: A PROPENSITY SCORE MATCHING ANALYSIS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.016, https://doi.org/10.1093/dote/doad052.016
44. LONG-TERM OUTCOMES OF PERORAL ENDOSCOPIC MYOTOMY FOR PATIENTS WITH ACHALASIA: A SINGLE-CENTRE STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.017, https://doi.org/10.1093/dote/doad052.017
46. THORACOSCOPIC REPAIR OF IATROGENIC INJURY TO THE THORACIC AORTA DURING MINIMALLY INVASIVE ESOPHAGECTOMY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.018, https://doi.org/10.1093/dote/doad052.018
47. PERORAL ENDOSCOPIC MYOTOMY VS HELLER MYOTOMY WITH FUNDOPLICATION IN OUR CENTER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.019, https://doi.org/10.1093/dote/doad052.019
135. IMPACT OF GENDER, RACE AND AGE OF ONSET ON THE PHENOTYPE AND COMORBIDITIES OF PEDIATRIC EOSINOPHILIC ESOPHAGITIS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.020, https://doi.org/10.1093/dote/doad052.020
136. IMPACT OF SKELETAL MUSCLE LOSS AND SARCOPENIA ON OUTCOMES OF LOCALLY ADVANCED ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.021, https://doi.org/10.1093/dote/doad052.021
137. THE COMPARISON OF UNIPORTAL VERSUS MULTIPORTAL VIDEO-ASSISTED THORACIC SURGERY FOR ESOPHAGEAL CANCER: A PROPENSITY-WEIGHTED ANALYSIS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.022, https://doi.org/10.1093/dote/doad052.022
142. EFFECTS OF PPIS AND P-CAB ON RESPONSES ACCORDING TO OUTCOMES OF SYMPTOM, ENDOSCOPY, AND HISTOLOGY IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.023, https://doi.org/10.1093/dote/doad052.023
143. NEOADJUVANT CHEMORADIOTHERAPY VERSUS CHEMOTHERAPY FOR THE TREATMENT OF LOCALLY ADVANCED ESOPHAGEAL ADENOCARCINOMA IN THE EUROPEAN MULTICENTER ENSURE STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.024, https://doi.org/10.1093/dote/doad052.024
144. OPTIMIZING MEDIASTINAL ACCESS FOR RADICAL ESOPHAGECTOMY: A BILATERAL CERVICAL AND TRANSHIATAL APPROACH TO RESECT ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.025, https://doi.org/10.1093/dote/doad052.025
145. PRECISE PATTERN OF LYMPHATIC SPREAD OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA RESULTS OF 1074 PATIENTS WITH N1 DISEASE
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.026, https://doi.org/10.1093/dote/doad052.026
147. CHARACTERISTICS AND PREDICTORS OF EARLY POSTOPERATIVE RECURRENCE OF ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.027, https://doi.org/10.1093/dote/doad052.027
148. COMPARISON OF EARLY POSTOPERATIVE OUTCOME BETWEEN OPEN AND MINIMALLY INVASIVE TRANSTHORACIC ESOPHAGECTOMY FOR ESOPHAGEAL CANCER: A RETROSPECTIVE STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.028, https://doi.org/10.1093/dote/doad052.028
149. LAPAROSCOPIC HELLER CARDIO-MYOTOMY IS NOT ALWAYS A SAFE OPERATION
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.029, https://doi.org/10.1093/dote/doad052.029
150. PATTERN OF LYMPH NODE RECURRENCE AFTER NEOADJUVANT CHEMORADIOTHERAPY AND MODIFIED EN BLOC ESOPHAGECTOMY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.030, https://doi.org/10.1093/dote/doad052.030
151. INFLUENCE OF PERIOPERATIVE ANEMIA ON MORBIDITY AND MORTALITY OUTCOMES AFTER RADICAL ESOPHAGECTOMY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.031, https://doi.org/10.1093/dote/doad052.031
152. SINTILIMAB PLUS CISPLATIN AND PACLITAXEL INDUCTION TREATMENT FOR BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II CLINICAL TRIAL
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.032, https://doi.org/10.1093/dote/doad052.032
153. PROPENSITY MATCHING ANALYSIS OF NEOADJUVANT CHEMORADIOTHERAPY AND NEOADJUVANT IMMUNOTHERAPY COMBINED WITH CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED ESCC
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.033, https://doi.org/10.1093/dote/doad052.033
154. EVALUATION OF BLOOD FLOW IN RECONSTRUCTED GASTRIC TUBE AND IDENTIFICATION OF OPTIMAL ANASTOMOSES IN ESOPHAGECTOMY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.034, https://doi.org/10.1093/dote/doad052.034
158. PACLITAXEL PLUS CISPLATIN AND 5 FUOROURACIL INDUCTION CHEMOTHERAPY FOR BORDERLINE RESECTABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: 3-YEAR SURVIVAL RESULT
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.035, https://doi.org/10.1093/dote/doad052.035
164. INTRAOPERATIVE LYMPHATIC FLOW MAPPING USING INDOCYANINE GREEN PREDICTS LYMPH NODE METASTASIS IN ESOPHAGEAL CANCER PATIENTS NOT TREATED WITH NEOADJUVANT CHEMOTHERAPY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.036, https://doi.org/10.1093/dote/doad052.036
166. ROBOTIC-ASSISTED BILATERAL EPIPHRENIC DIVERTICULECTOMY WITH HELLER MYOTOMY AND DOR FUNDOPLICATION: A SURGICAL TECHNIQUE
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.037, https://doi.org/10.1093/dote/doad052.037
167. NATIONAL TRENDS IN TECHNIQUE UTILIZATION FOR ESOPHAGECTOMY: DOES PRIMARY SURGEON SPECIALTY MATTER?
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.038, https://doi.org/10.1093/dote/doad052.038
169. PROPENSITY SCORE MATCHING ANALYSIS OF THE EFFECT ON PROGNOSIS OF PROPHYLACTIC NECK DISSECTION FOR ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.039, https://doi.org/10.1093/dote/doad052.039
173. FEASIBILITY AND POTENTIAL ADVANTAGE OF ROBOT-ASSISTED ESOPHAGECTOMY FOR CT4B ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.040, https://doi.org/10.1093/dote/doad052.040
175. OPTIMIZING MEDIASTINAL ACCESS FOR RADICAL ESOPHAGECTOMY: A BILATERAL CERVICAL AND TRANSHIATAL APPROACH TO RESECT ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.041, https://doi.org/10.1093/dote/doad052.041
176. NON-REGIONAL LYMPHADENOPATHY IN PATIENTS WITH ESOPHAGEAL CANCER TREATED WITH CURATIVE INTENT: A PROPENSITY MATCHED ANALYSIS OF PATHOLOGICAL AND SURVIVAL OUTCOMES
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.042, https://doi.org/10.1093/dote/doad052.042
177. BULKY LYMPHADENOPATHY IN ESOPHAGEAL CANCER: ASSESSING PATHOLOGICAL AND SURVIVAL OUTCOMES AFTER TREATMENT WITH CURATIVE INTENT
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.043, https://doi.org/10.1093/dote/doad052.043
178. OUTCOME OF DOCETAXEL, CISPLATIN, AND 5-FLUOROURACIL COMBINATION CHEMORADIOTHERAPY FOR LOCALLY ADVANCED ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.044, https://doi.org/10.1093/dote/doad052.044
180. ENHANCED RECOVERY PROTOCOL VERSUS CONVENTIONAL CARE IN ESOPHAGECTOMY PATIENTS WITH ESOPHAGEAL CARCINOMA: ADVANTAGES ON THE PATIENT-REPORTED OUTCOMES
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.045, https://doi.org/10.1093/dote/doad052.045
181. SAFETY AND TIME USAGE OF CIRCULAR STAPLED ANASTOMOSIS IN THE SHIFT FROM MIE TO RAMIE
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.046, https://doi.org/10.1093/dote/doad052.046
183. NEOADJUVANT CAMRELIZUMAB PLUS CHEMOTHERAPY (NICE) VERSUS CROSS REGIMENS IN OESOPHAGEAL SQUAMOUS CELL CARCINOMA, A PROPENSITY-SCORE MATCHED ANALYSIS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.047, https://doi.org/10.1093/dote/doad052.047
184. INTRATHORACIC SIDE-OVERLAP ESOPHAGOGASTROSTOMY DURING MINIMALLY INVASIVE ESOPHAGECTOMY FOR ESOPHAGOGASTRIC JUNCTION CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.048, https://doi.org/10.1093/dote/doad052.048
186. PROGNOSTIC ROLE OF NODAL SKIP METASTASIS IN THORACIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A LARGE-SCALE MULTICENTER STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.049, https://doi.org/10.1093/dote/doad052.049
187. PROGNOSTIC IMPACT OF LYMPH NODE HARVEST FOR PATIENTS WITH NODE-NEGATIVE ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A LARGE-SCALE MULTICENTER STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.050, https://doi.org/10.1093/dote/doad052.050
188. VITAMIN D RECEPTOR INDUCES OXIDATIVE STRESS TO PROMOTE ESOPHAGEAL SQUAMOUS CELL CARCINOMA PROLIFERATION VIA THE P53 SIGNALING PATHWAY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.051, https://doi.org/10.1093/dote/doad052.051
189. IDENTIFICATION OF M6A-RELATED SIGNATURE GENES IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA BY MACHINE LEARNING METHOD
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.052, https://doi.org/10.1093/dote/doad052.052
190. PROGNOSTIC VALUE OF COMBINATION OF LYMPHOCYTE-TO-MONOCYTE-RATIO AND CYFRA 21-1 IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.053, https://doi.org/10.1093/dote/doad052.053
191. CIRCULATING TUMOR DNA (CTDNA) ANALYSIS FOR DETECTION OF RESIDUAL DISEASE AFTER NEOADJUVANT CHEMORADIOTHERAPY (NCRT) FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC)
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.054, https://doi.org/10.1093/dote/doad052.054
193. RORY+ NEUTROPHILS: A NOVEL THERAPEUTIC TARGET IN GASTRO-ESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.055, https://doi.org/10.1093/dote/doad052.055
194. INTENSIVE SURVEILLANCE INCREASES SALVAGE SURGERY AND SURVIVAL RATES FOR ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.056, https://doi.org/10.1093/dote/doad052.056
195. OUTCOME OF A PATIENT CHOICE PROTOCOL OF SURGERY OR SURVEILLANCE FOR CLINICAL COMPLETE RESPONDERS TO NEOADJUVANT CHEMORADIOTHERAPY FOR ESOPHAGEAL CARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.057, https://doi.org/10.1093/dote/doad052.057
196. MINIMALLY INVASIVE ESOPHAGECTOMY WITH AWARENESS OF THE THIN MEMBRANOUS DENSE CONNECTIVE TISSUES AROUND THE ESOPHAGUS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.058, https://doi.org/10.1093/dote/doad052.058
197. FIBROSING MEDIASTINITIS CAUSING CONCOMITANT FOCAL STRICTURE AND TRACTION DIVERTICULA OF THE ESOPHAGUS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.059, https://doi.org/10.1093/dote/doad052.059
198. MODELING CANCER CACHEXIA USING PATIENT TUMOR ORGANOID-DERIVED XENOGRAFTS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.060, https://doi.org/10.1093/dote/doad052.060
200. COMPARISON OF SHORT-TERM OUTCOMES BETWEEN TRANSTHORACIC AND ROBOT-ASSISTED TRANSMEDIASTINAL RADICAL SURGERY FOR ESOPHAGEAL CANCER: A PROSPECTIVE STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.061, https://doi.org/10.1093/dote/doad052.061
201. PREOPERATIVE HANDGRIP STRENGTH IS ASSOCIATED WITH POSTOPERATIVE PULMONARY COMPLICATIONS AFTER MAJOR ABDOMINAL SURGERY: A PROSPECTIVE MULTICENTRE INTERNATIONAL COHORT STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.062, https://doi.org/10.1093/dote/doad052.062
202. AN ARTIFICIAL INTELLIGENCE ALGORITHM FOR DETECTION OF CIRCULATING TUMOR CELLS IN PATIENTS WITH ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.063, https://doi.org/10.1093/dote/doad052.063
203. SURVIVAL IMPACT OF THORACIC DUCT RESECTION IN PATHOLOGICAL RESPONDERS AFTER TRIPLET CHEMOTHERAPY: EXPLORATORY ANALYSIS FROM MULTICENTER PHASE III TRIAL JCOG1109
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.064, https://doi.org/10.1093/dote/doad052.064
204. CORRELATION OF CIRCULATING T LYMPHOCYTES WITH RESPONSE TO NEOADJUVANT CHEMOIMMUNOTHERAPY IN OPERABLE ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.065, https://doi.org/10.1093/dote/doad052.065
205. LONGITUDINAL PATIENT-REPORTED OUTCOMES AFTER MINIMALLY INVASIVE MCKEOWN ESOPHAGECTOMY IN PATIENTS WITH ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.066, https://doi.org/10.1093/dote/doad052.066
210. BIORESORBABLE SYNTHETIC MESHES IN LARGE PARAESOPHAGEAL HERNIAS. TECHNIQUE OF APLICATION AND EARLY RESULTS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.067, https://doi.org/10.1093/dote/doad052.067
212. ROBOT ASSISTED ESOPHAGECTOMY WITH EXTENDED MEDIASTINAL LYMPH NODE DISSECTION
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.068, https://doi.org/10.1093/dote/doad052.068
216. SHORT-TERM OUTCOMES OF 111 CASES OF MEDIASTINOSCOPIC ESOPHAGECTOMY FOR ALL ESOPHAGEAL CANCERS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.069, https://doi.org/10.1093/dote/doad052.069
217. IMPORTANCE OF PERFORMING BARIUM SWALLOW TEST FOR COLLECT DIAGNOSIS OF ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION INCLUDING ACHALASIA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.070, https://doi.org/10.1093/dote/doad052.070
218. INITIAL EXPERIENCES WITH VACUUM-STENT AS NOVEL TREATMENT OPTION FOR TRANSMURAL DEFECTS IN THE UPPER GASTRO-INTESTINAL TRACT: A SINGLE-CENTER CASE SERIES
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.071, https://doi.org/10.1093/dote/doad052.071
219. ASSOCIATION BETWEEN VIDEO-BASED SURGICAL PERFORMANCE AND PATIENT OUTCOMES IN MINIMALLY INVASIVE ESOPHAGECTOMY IN THE NETHERLANDS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.072, https://doi.org/10.1093/dote/doad052.072
220. INDUCTION CHEMOTHERAPY FOLLOWED BY RESTAGING AND SURGERY FOR ADVANCED ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.073, https://doi.org/10.1093/dote/doad052.073
221. INTERVAL METASTASES AFTER NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL CANCER: A MULTICENTER OBSERVATIONAL COHORT STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.074, https://doi.org/10.1093/dote/doad052.074
223. UNDERSTANDING POTENTIALLY PREVENTABLE MORTALITY FOLLOWING ESOPHAGO-GASTRIC CANCER SURGERY: ANALYSIS OF A NATIONAL AUDIT OF SURGICAL MORTALITY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.075, https://doi.org/10.1093/dote/doad052.075
224. A SUCCESSFUL CASE OF VACUUM-STENT TREATMENT FOR BOERHAAVE SYNDROME
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.076, https://doi.org/10.1093/dote/doad052.076
225. PREDICTORS OF ANASTOMOTIC LEAK AMONG PATIENTS UNDERGOING ESOPHAGECTOMY: A RETROSPECTIVE COHORT OF 6669 PATIENTS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.077, https://doi.org/10.1093/dote/doad052.077
227. RELATIONSHIP BETWEEN 90-DAY PROGNOSIS NUTRITIONAL INDEX AND INFLAMMATORY RESPONSE MARKERS AND LONG-TERM SURVIVAL IN ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.078, https://doi.org/10.1093/dote/doad052.078
228. THORACOACROMIAL ARTERY PERFORATOR FLAP REPAIR OF ACQUIRED INTRATHORACIC NONMALIGNANT TRACHEOESOPHAGEAL FISTULAS THROUGH A MIDSTERNAL INCISION APPROACH
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.079, https://doi.org/10.1093/dote/doad052.079
229. WEST-CHINA MODE IN MEDIASTINOSCOPE-ASSISTED TRANSHIATAL ESOPHAGECTOMY: A MORE MATURE AND VERSATILE TRANSHIATAL ESOPHAGECTOMY PROCEDURE
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.080, https://doi.org/10.1093/dote/doad052.080
230. SURVIVAL OUTCOMES OF ROBOT-ASSISTED TRANS-MEDIASTIONAL ESOPHAGECTOMY IN PATIENTS WITH CT1N0 ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.081, https://doi.org/10.1093/dote/doad052.081
231. ROBOT-ASSISTED TRANSMEDIASTINAL (TRANSCERVICAL & TRANSHIATAL) ESOPHAGECTOMY FOR ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.082, https://doi.org/10.1093/dote/doad052.082
236. INDOCYANINE GREEN TRACHEOBRONCHIAL FLUORESCENCE (ICG-TBF) VIA NEBULIZATION DURING MINIMALLY INVASIVE ESOPHAGECTOMY -A NOVEL TECHNIQUE
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.083, https://doi.org/10.1093/dote/doad052.083
237. PRE-NEOADJUVANT CHEMOTHERAPY SARCOPENIA IS PREDICTIVE OF MORTALITY IN ESOPHAGOGASTRIC ADENOCARCINOMA PATIENTS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.084, https://doi.org/10.1093/dote/doad052.084
238. ESOPHAGOGASTRIC ADENOCARCINOMA PATIENTS WITH SARCOPENIA BEFORE OR AFTER NEOADJUVANT CHEMOTHERAPY ARE MORE LIKELY TO HAVE LONGER POST-OPERATIVE INPATIENT STAYS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.085, https://doi.org/10.1093/dote/doad052.085
241. EVALUATION OF THE PYLORUS FOLLOWING GASTRIC CONDUIT RECONSTRUCTION IN OESOPHAGECTOMY USING IMPEDANCE PLANIMETRY—A SYSTEMATIC REVIEW WITH META-ANALYSIS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.086, https://doi.org/10.1093/dote/doad052.086
243. COMPARISON BETWEEN THE THERAPEUTIC AND PROPHYLACTIC LYMPHADENECTOMY OF THE SUPRACLAVICULAR AREA FOR PATIENTS WITH ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.087, https://doi.org/10.1093/dote/doad052.087
244. A NOVEL SERUM GLYCOPROTEIN BIOMARKER PANEL FOR SCREENING OF ESOPHAGEAL ADENOCARCINOMA AND SURVEILLANCE OF BARRETT’S ESOPHAGUS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.088, https://doi.org/10.1093/dote/doad052.088
245. CONVERSION SURGERY AFTER DEINITIVE CHEMORADIOTHERAPY FOR THORACIC ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.089, https://doi.org/10.1093/dote/doad052.089
246. SPATIAL HETEROGENEITY OF PD-L1 EXPRESSION INFLUENCE ITS ASSESSMENT IN ESOPHAGEAL SQUAMOUS CARCINOMA (ESCC)
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.090, https://doi.org/10.1093/dote/doad052.090
247. TARGETING HAUS7/GAMMA-TUBULIN INTERACTION WITH HTIP1 SUPPRESSES TUMORIGENESIS IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.091, https://doi.org/10.1093/dote/doad052.091
248. SYSTEMIC INFLAMMATORY MARKERS AS PROGNOSTIC FACTORS IN ESOPHAGEAL CANCER: A MEXICAN PERSPECTIVE
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.092, https://doi.org/10.1093/dote/doad052.092
249. AUTOMATED PREDICTION SYSTEM USING COMPUTER VISION FOR ESOPHAGEAL STRICTURE AFTER ESOPHAGEAL ENDOSCOPIC RESECTION
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.093, https://doi.org/10.1093/dote/doad052.093
250. ASSOCIATION OF SLING-FIBER PRESERVATION POEM AND POST-POEM GERD SYMPTOMS: A NORTH AMERICAN SINGLE-CENTER RETROSPECTIVE STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.094, https://doi.org/10.1093/dote/doad052.094
253. ESOPHAGEAL REGENERATION FOLLOWING IMPLANTATION OF A TISSUE ENGINEERED ESOPHAGEAL IMPLANT: UNDERSTANDING THE REGENERATION TIME COURSE AND TRANSLATION TO THE CLINIC
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.095, https://doi.org/10.1093/dote/doad052.095
254. THE IMPACT OF D2 VERSUS D1 LYMPHADENECTOMY IN SIEWERT II GASTROESOPHAGEAL JUNCTION (GEJ) CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.096, https://doi.org/10.1093/dote/doad052.096
255. EARLY COST-EFFECTIVENESS MODELLING STUDY COMPARING MINIMALLY INVASIVE TRANSCERVICAL ESOPHAGECTOMY (MICE) AND TRANSTHORACIC MINIMALLY INVASIVE ESOPHAGECTOMY (TMIE) IN OESOPHAGEAL CANCER PATIENTS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.097, https://doi.org/10.1093/dote/doad052.097
256. OPERATIVE TIMES FOR MINIMALLY INVASIVE ESOPHAGECTOMY (MIE): IS THERE AN EFFECT ON OUTCOMES?
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.098, https://doi.org/10.1093/dote/doad052.098
257. UPDATE OF THE INTRODUCTION OF MINIMALLY INVASIVE TRANSCERVICAL ESOPHAGECTOMY (MICE), CLINICAL OUTCOMES OF THE LEARNING CURVE COHORT
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.099, https://doi.org/10.1093/dote/doad052.099
258. A VIDEO-UPDATE OF THE LEARNING CURVE OF THE INTRODUCTION OF MINIMALLY INVASIVE TRANSCERVICAL ESOPHAGECTOMY (MICE)
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.100, https://doi.org/10.1093/dote/doad052.100
259. ROBOTIC ESOPHAGECTOMY AND THREE FIELD LYMPHADENECTOMY WITH INTRA-OPERATIVE RECURRENT LARYNGEAL NERVE MONITORING
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.101, https://doi.org/10.1093/dote/doad052.101
261. THE PROGNOSTIC IMPACT OF PRE-OPERATIVE NUTRITIONAL INDICATORS OF THE PATIENTS WITH ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.102, https://doi.org/10.1093/dote/doad052.102
262. DUPILUMAB REDUCED EOSINOPHIL COUNTS AND IMPROVED HISTOLOGY GRADE/STAGE SCORES IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: LIBERTY EOE TREET RESULTS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.103, https://doi.org/10.1093/dote/doad052.103
263. DUPILUMAB EFFICACY AND SAFETY TO 52 WEEKS IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM LIBERTY EOE TREET
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.104, https://doi.org/10.1093/dote/doad052.104
264. A RETROSPECTIVE CHART REVIEW OF 85 PATIENTS UNDERGOING THE REFLUXSTOP PROCEDURE TO MANAGE GASTROESOPHAGEAL REFLUX DISEASE: SAFETY AND EFFICACY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.105, https://doi.org/10.1093/dote/doad052.105
267. IDENTIFYING CANCER-ASSOCIATED FIBROBLAST POPULATIONS DRIVING THERAPY RESISTANCE IN GASTROESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.106, https://doi.org/10.1093/dote/doad052.106
268. DEVELOPMENT OF A NOVEL ESOPHAGUS-ON-A-CHIP MODEL: A HIGH-FIDELITY PLATFORM FOR DIRECTING PERSONALIZED THERAPY IN ESOPHAGEAL ADENOCARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.107, https://doi.org/10.1093/dote/doad052.107
269. CURRENT STATUS OF THE INTRODUCTION PROCESS OF MINIMALLY INVASIVE TRANSCERVICAL ESOPHAGECTOMY (MICE), TYPICALLY IDEAL 2A STRUGGLES
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.108, https://doi.org/10.1093/dote/doad052.108
270. PERIOPERATIVE CHEMOTHERAPY FOR OPERABLE GASTRO-ESOPHAGEAL JUNCTION OR GASTRIC CANCER: FLOT VERSUS ANTHRACYCLINE TRIPLETS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.109, https://doi.org/10.1093/dote/doad052.109
274. ROBOTIC-ASSISTED THORACOSCOPIC ESOPHAGECTOMY WITH MEDIASTINAL LYMPH NODE DISSECTION: DOES IT FEASIBLE FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA SURGERY?
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.110, https://doi.org/10.1093/dote/doad052.110
277. SIMPLE METHOD: INGUINAL LYMPHANGIOGRAPHY FOR POSTOPERATIVE CHYLOTHORAX
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.111, https://doi.org/10.1093/dote/doad052.111
278. MEDIASTINOSCOPIC ESOPHAGECTOMY WITH INTRAOPERATIVE NERVE MONITORING FOR ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMA; A SINGLE-CENTER INITIAL EXPERIENCE
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.112, https://doi.org/10.1093/dote/doad052.112
279. ENDOSCOPIC RENDEZVOUS TECHNIQUE FOR RECANALIZATION OF COMPLETE ESOPHAGEAL OBLITERATION
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.113, https://doi.org/10.1093/dote/doad052.113
280. FEASIBILITY OF ROBOTIC-ASSISTED SURGERY FOR BENIGN ESOPHAGEAL LESIONS: SINGLE-CENTER EXPERIENCE
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.114, https://doi.org/10.1093/dote/doad052.114
281. TOTAL LAPAROSCOPIC VERSUS OPEN GASTRIC PULL-UP FOLLOWING MINIMALLY INVASIVE THORACOSCOPIC ESOPHAGECTOMY FOR ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.115, https://doi.org/10.1093/dote/doad052.115
283. 18F-FDG PET/MRI FOR RESTAGING ESOPHAGEAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.116, https://doi.org/10.1093/dote/doad052.116
286. A BIBLIOMETRIC ANALYSIS OF NEOADJUVANT THERAPY FOR ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.117, https://doi.org/10.1093/dote/doad052.117
288. POST-OPERATIVE COMPLICATIONS IN OBESE SARCOPENIC PATIENTS WITH ESOPHAGOGASTRIC ADENOCARCINOMA UNDERGOING NEOADJUVANT CHEMOTHERAPY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.118, https://doi.org/10.1093/dote/doad052.118
289. RISK FACTOR OF RELAPSE IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA WHO ACHIEVE PATHOLOGIC COMPLETE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.119, https://doi.org/10.1093/dote/doad052.119
290. RISK OF ESOPHAGEAL CANCER AFTER BARIATRIC SURGERY: COMPARISON BETWEEN SLEEVE GASTRECTOMY AND GASTRIC BYPASS AT 10 YEARS, A NATIONWIDE STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.120, https://doi.org/10.1093/dote/doad052.120
291. TREATMENT OUTCOMES ACCORDING TO PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMORADIATION AND SURGEY IN OESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.121, https://doi.org/10.1093/dote/doad052.121
292. SPECIFIC METHYLATION MARKERS ASSOCIATED WITH CHANGES IN GENE EXPRESSION DISTINGUISH EAC AND SUB-TYPES OF BE PATIENTS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.122, https://doi.org/10.1093/dote/doad052.122
295. RELATIONSHIP BETWEEN ABDOMINAL FAT DISTRIBUTION AND PROGRESSION OF BARRETT’S ESOPHAGUS TO ADENOCARCINOMA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.123, https://doi.org/10.1093/dote/doad052.123
296. FIBRIN SEALANT FOR THE PREVENTION OF ANASTOMOTIC LEAKAGE AFTER ESOPHAGECTOMY: INTERIM REPORT OF A PROSPECTIVE, PHASE III, RANDOMIZED CONTROLLED STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.124, https://doi.org/10.1093/dote/doad052.124
299. OPTIMAL NUMBER OF NEOADJUVANT IMMUNOTHERAPY AND CHEMOTHERAPY CYCLES IN ADVANCED ESOPHAGEAL CANCER TREATMENT
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.125, https://doi.org/10.1093/dote/doad052.125
300. ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ESOPHAGEAL ADENOCARCINOMA: PRELIMINARY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.126, https://doi.org/10.1093/dote/doad052.126
301. DIFFERENCES IN MULTIDISCIPLINARY CANCER CONFERENCES OF ESOPHAGEAL AND GASTROESOPHAGEAL JUNCTIONAL CANCER REGARDING STAGING AND TREATMENT ALLOCATION—A MULTICENTER STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.127, https://doi.org/10.1093/dote/doad052.127
302. IMPACT OF ERAS BENCHMARK ACHIEVEMENTS AND HYBRID ROBOTIC ASSISTED ESOPHAGECTOMY ON RECOVERY AND READMISSION IN AN ERAS CENTER OVER TIME
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.128, https://doi.org/10.1093/dote/doad052.128
303. THE TISSUE SYSTEMS PATHOLOGY-9 TEST PROVIDES CLINICALLY-IMPACTFUL RISK STRATIFICATION IN PATIENTS WITH BARRETT’S ESOPHAGUS: CLINICAL EXPERIENCE IN A MULTICENTER COHORT
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.129, https://doi.org/10.1093/dote/doad052.129
307. A REVIEW OF 31 SUPERFICIAL ESOPHAGEAL CANCER CASES WITHOUT HISTORY OF HABITUAL DRINKING OR SMOKING OBSERVED IN OUR HOSPITAL
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.130, https://doi.org/10.1093/dote/doad052.130
309. SURGICAL TREATMENT FOR THE RECURRENT SITE OF ESOPHAGEAL CANCER AFTER ESOPHAGECTOMY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.131, https://doi.org/10.1093/dote/doad052.131
311. H ANASTOMOSIS FOR LOW INCIDENCE OF ANASTOMOTIC LEAKAGE, OBSTRUCTION AND GASTROESOPHAGEAL REFLUX
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.132, https://doi.org/10.1093/dote/doad052.132
312. H ANASTOMOSIS IN MECKOWN ESOPHAGECTOMY FOR THE REDUCED ANASTOMOTIC LEAKAGE, OBSTRUCTION, AND GASTROESOPHAGEAL REFLUX
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.133, https://doi.org/10.1093/dote/doad052.133
313. EXPERIENCE OF 4 CASES TREATED WITH IPI + NIVO FOR RECURRENT ADVANCED ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.134, https://doi.org/10.1093/dote/doad052.134
314. CLINICAL OUTCOME OF ICI COMBINATION THERAPY AS 1ST LINE TREATMENT FOR ESOPHAGEAL CANCER
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.135, https://doi.org/10.1093/dote/doad052.135
315. LAPAROSCOPIC GASTRIC PULL-UP WITH GASTROJEJUNOSTOMY AS AN ALTERNATIVE TO COLON-TRANSPOSITION FOR CORROSIVE STRICTURE INVOLVING OESOPHAGUS AND ANTROPYLORIC REGION OF STOMACH
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.136, https://doi.org/10.1093/dote/doad052.136
317. A NOVEL TECHNIQUE OF ‘SUPERCHARGED ELONGATED GASTRIC TUBE’ FOR THE MANAGEMENT OF CORROSIVE PHARYNGEAL STRICTURE
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.137, https://doi.org/10.1093/dote/doad052.137
318. THE INFLUENCE OF AGE IN OESOPHAGEAL CANCER TREATMENT DECISIONS: A MACHINE-LEARNING APPROACH
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.138, https://doi.org/10.1093/dote/doad052.138
319. A SUCCESSFUL CASE OF VACUUM-STENT TREATMENT FOR ANASTOMOTIC LEAKAGE AFTER ESOPHAGECTOMY WITH COMPLICATED POST-SURGICAL COURSE
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.139, https://doi.org/10.1093/dote/doad052.139
320. ESOPHAGEAL PULL-DOWN TECHNIQUE IMPROVES THE FINAL OUTCOME OF LAPAROSCOPIC HELLER-DOR FOR END-STAGE ACHALASIA
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.140, https://doi.org/10.1093/dote/doad052.140
321. ESD AND ELPS A NOVEL MINIMALLY INVASIVE TREATMENT FOR MULTI-EPISODE SUPERFICIAL ESOPHAGEAL SCC AND 2ND PRIMARY HYPOPHARYNGEAL SCC:A CASE REPORT
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.141, https://doi.org/10.1093/dote/doad052.141
322. FLUORESCENCE LYMPHOGRAPHY USING INDOCYANINE GREEN IN THE PREVENTION OF CHYLE LEAKAGE AFTER MINIMALLY INVASIVE ESOPHAGECTOMY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.142, https://doi.org/10.1093/dote/doad052.142
325. CAMRELIZUMAB IN COMBINATION WITH CHEMOTHERAPY VERSUS CHEMORADIOTHERAPY FOR THE CONVERSION OF UNRESECTABLE ESOPHAGEAL CARCINOMA: A PROSPECTIVE CLINICAL STUDY PROTOCOL
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.143, https://doi.org/10.1093/dote/doad052.143
326. LONG-TERM OUTCOMES OF MODIFIED ENHANCED RECOVERY AFTER SURGERY (MERAS) PROTOCOLS IN PERI-OPERATIVE MANAGEMENT OF MINIMALLY INVASIVE ESOPHAGECTOMY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.144, https://doi.org/10.1093/dote/doad052.144
327. ANALYSING THE ROLE OF PET-CT IN ESOPHAGEAL CANCER: A SINGLE CENTRE COHORT STUDY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.145, https://doi.org/10.1093/dote/doad052.145
328. ENDOSCOPIC SUBMUCOSAL DISSECTION FOR SUPERFICIAL ESOPHAGEAL CARCINOMA INVOLVING THE ENTIRE ESOPHAGUS: SHORT-TERM RESULTS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.146, https://doi.org/10.1093/dote/doad052.146
330. PRE-EMPTIVE ENDOLUMINAL VACUUM THERAPY WITH A SURGICAL DRAIN FOR REDUCTION OF ANASTOMOTIC LEAK RATE FOLLOWING MINIMALLY INVASIVE ESOPHAGECTOMY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.147, https://doi.org/10.1093/dote/doad052.147
331. IMPACT OF SARCOPENIA ON RECURRENCE OF ESOPHAGOGASTRIC ADENOCARCINOMA IN PATIENTS THAT HAVE UNDERGONE NEOADJUVANT CHEMOTHERAPY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.148, https://doi.org/10.1093/dote/doad052.148
332. NO NEED FOR A SPONGE! ENDOLUMINAL VACUUM THERAPY WITH A SIMPLE FENESTRATED SURGICAL DRAIN FOR MANAGEMENT OF BENIGN OESOPHAGEAL PERFORATIONS
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.149, https://doi.org/10.1093/dote/doad052.149
333. HIGH CERVICAL ANASTOMOSIS USING NARROW GASTRIC TUBE CAN REDUCE LEAKAGE AFTER MCKEOWN ESOPHAGECTOMY
Diseases of the Esophagus, Volume 36, Issue Supplement_2, September 2023, doad052.150, https://doi.org/10.1093/dote/doad052.150
